Association of plasma clusterin concentration with severity, pathology, and progression in Alzheimer disease. - sprookjes - yvandenbroek - TriplyDB

Association of plasma clusterin concentration with severity, pathology, and progression in Alzheimer disease.

Association of plasma clusterin concentration with severity, pathology, and progression in Alzheimer disease.

http://www.wikidata.org/entity/Q35034130

about

Genetics of late-onset Alzheimer's disease: update from the alzgene database and analysis of shared pathways Identification of candidate IgG biomarkers for Alzheimer's disease via combinatorial library screening Blood-Based Proteomic Biomarkers of Alzheimer's Disease Pathology The complotype: dictating risk for inflammation and infection Late-Onset Alzheimer's Disease Genes and the Potentially Implicated Pathways Amyloid β: one of three danger-associated molecules that are secondary inducers of the proinflammatory cytokines that mediate Alzheimer's disease Apolipoprotein J/Clusterin is a novel structural component of human erythrocytes and a biomarker of cellular stress and senescence Proteomic Analysis of Vitreous Humor in Retinal Vein Occlusion Dietary oil modifies the plasma proteome during aging in the rat Plasma biomarkers of brain atrophy in Alzheimer's disease Sensitivity and specificity of medial temporal lobe visual ratings and multivariate regional MRI classification in Alzheimer's disease Clusterin regulates β-amyloid toxicity via Dickkopf-1-driven induction of the wnt-PCP-JNK pathway Precuneus and Cingulate Cortex Atrophy and Hypometabolism in Patients with Alzheimer's Disease and Mild Cognitive Impairment: MRI and (18)F-FDG PET Quantitative Analysis Using FreeSurfer.Markers of cholesterol transport are associated with amyloid deposition in the brain.Transcriptomics of cortical gray matter thickness decline during normal aging Functional and genetic analysis of choroid plexus development in zebrafish.TheHiveDB image data management and analysis framework.Genome-wide significant risk factors for Alzheimer's disease: role in progression to dementia due to Alzheimer's disease among subjects with mild cognitive impairment Identification of serum biomarkers in dogs naturally infected with Babesia canis canis using a proteomic approach.Circulating biomarkers that predict incident dementia.[Diagnosis without therapy: early diagnosis of Alzheimer's disease in the stage of mild cognitive impairment].Blood-based biomarkers of Alzheimer's disease: challenging but feasible Application of a MRI based index to longitudinal atrophy change in Alzheimer disease, mild cognitive impairment and healthy older individuals in the AddNeuroMed cohort.Plasma biomarkers are associated with agitation and regional brain atrophy in Alzheimer's disease.Plasma clusterin (ApoJ) levels are associated with adiposity and systemic inflammation.The role of clusterin in amyloid-β-associated neurodegeneration.The future of blood-based biomarkers for Alzheimer's disease.Meta-profiles of gene expression during aging: limited similarities between mouse and human and an unexpectedly decreased inflammatory signature.Genetics of clusterin isoform expression and Alzheimer's disease risk.Genetics of dementia.Plasma apolipoprotein levels are associated with cognitive status and decline in a community cohort of older individuals.Developing novel blood-based biomarkers for Alzheimer's disease Alzheimer's disease risk genes and mechanisms of disease pathogenesis Plasma based markers of [11C] PiB-PET brain amyloid burden.No diagnostic value of plasma clusterin in Alzheimer's disease.Plasma proteins predict conversion to dementia from prodromal disease Proteome-based plasma markers of brain amyloid-β deposition in non-demented older individuals.Alterations in brain leptin signalling in spite of unchanged CSF leptin levels in Alzheimer's disease.Brain amyloidosis ascertainment from cognitive, imaging, and peripheral blood protein measures Brain interleukin-1β and the intrinsic receptor antagonist control peripheral Toll-like receptor 3-mediated suppression of spontaneous activity in rats.

P2860

Q24629875-32BFE98B-0FB5-4528-8A92-72F270E161EA Q24630334-DDA12B3E-5668-445C-9FD0-8E2884ECF9AF Q26774743-FFFA3240-C34A-4EBC-BA22-CF9002DC1A8F Q26862665-B337769D-76DE-42B3-88AF-564A3C24AA8D Q27014964-8E37B468-460A-4B95-9679-70C017B17646 Q28384947-560731B0-5243-4B28-8F88-A7094F378367 Q28477397-DA9FFEFD-281F-470C-8056-A824312DAF79 Q28552292-F35418DD-8126-4FC6-A102-00370B5EB227 Q28569420-856164A1-326B-4F52-8CE6-C07523809F9E Q28741028-A41547C6-4F35-4F07-B17E-D4BDFEFE2FEB Q28742333-CCA45F95-8BD3-4042-BF10-B4040FE7AAB7 Q29870999-73A97838-5F71-4582-A0DA-98FE3671CA96 Q30403393-4AA87280-1360-49D5-A419-916C91C84F48 Q30406139-1046D2BC-9BC2-4303-AB21-72F2CCA242EB Q30543926-7FE7E38B-4CEF-4F26-914B-EFC530647B37 Q30597227-908BF840-030A-492B-AA15-575F67651C50 Q30734877-CFAF9523-25E6-4F06-8859-DE28134F36DC Q33629452-F91D2E8C-C2E9-4A71-9436-B206AF0E838A Q33712315-A38110EF-705D-440C-95C9-68D05733A0FC Q33752058-B31FF24E-D6D2-421B-A23C-35858E6C07D5 Q33789963-E458C3F6-EB86-4DCC-B563-EF1749F14962 Q33824444-78B3365E-02FC-4868-96BC-507653FF12C5 Q33891581-5511216D-75F8-48B5-9ED9-07FD28A0323A Q33895177-9DC92544-5982-4D0E-A585-C98BEF8EE451 Q33975263-15D2FD20-5200-434B-8045-2F7D4F7C525F Q33988464-A54AF19F-4F8C-429A-BD29-47A45B66DE80 Q34026317-AB582ABD-9968-4E37-88F7-2E0943AD6C47 Q34193722-E37E3CAC-C72F-4B91-8B2B-A4FC84A0067A Q34233544-6CEB4932-50E1-46C9-B0AF-07A3EB1A4963 Q34248849-04FD9DF9-A849-4412-9988-D59FB03F0963 Q34305083-82535EF2-1FAB-4368-9769-E9C3828188C0 Q34394080-5E158153-8A7F-46FE-AB69-B5B5D10A2741 Q34425904-EA4F09C0-99E7-4B81-961A-57E773E6995A Q34427001-59A0B5AD-7544-4CF3-AAB4-890D2F6CA9EA Q34500043-3E3799B5-40C5-4C3C-AECD-ADEF9E56D007 Q34556953-ABFF2141-08E4-40A8-BE50-1DA60F33CEFC Q35076119-9ED9F9EA-24E8-419F-84BF-22A260A70ACE Q35080530-1FC8AE96-149A-40EB-B115-77A7C1AC43AD Q35106592-37D6731D-1308-45BF-B709-6EFAF48237F7 Q35118685-1F7529DB-A734-4D07-967F-57C5C629233B

P2860

Association of plasma clusterin concentration with severity, pathology, and progression in Alzheimer disease.

http://www.wikidata.org/entity/Q35034130

description

2010 nî lūn-bûn

@nan

2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Association of plasma clusteri ...... gression in Alzheimer disease.

@ast

Association of plasma clusteri ...... gression in Alzheimer disease.

@en

type

label

Association of plasma clusteri ...... gression in Alzheimer disease.

@ast

Association of plasma clusteri ...... gression in Alzheimer disease.

@en

prefLabel

Association of plasma clusteri ...... gression in Alzheimer disease.

@ast

Association of plasma clusteri ...... gression in Alzheimer disease.

@en

P1433

Q35034130-718351CD-A708-4D55-8189-1BAAEB9CE236

P1476

Q35034130-A83809F5-24CC-471F-A6CE-71D943CB497C

P2093

Q35034130-1DB0ADC1-E90B-4C7B-9FB3-4130F4A7642F

Q35034130-29535A17-277E-4BDD-87C2-CD7607021449

Q35034130-2F1B123D-7856-47E7-B28E-7AB7D375AF0F

Q35034130-44BFE983-349B-440D-B370-D60E718BCC36

Q35034130-4602572B-D273-438F-BD0D-3DC23F4D18BE

Q35034130-532A4C6D-4AA8-4E1A-A0A6-CCCB5AA5B44F

Q35034130-54F56C4F-FDA3-41D7-BE17-A8305AA4B212

Q35034130-5F6CE63A-41AB-40DA-B773-FEAE1A51462A

Q35034130-7A1E3F8D-3937-48AE-8577-82BB3D1AA1CA

Q35034130-9107C455-A333-4A1C-B30A-D97B1FD37DC4

P2860

Q35034130-02BE9C7D-06C0-48A1-9715-A98D42949F4B

Q35034130-02D7D463-EA71-4792-B81E-B720CA1A37DF

Q35034130-0D01F787-37D2-4B23-92A7-5D003881F166

Q35034130-0D27D340-AB5C-46B3-B191-64C2D3797D21

Q35034130-11057F63-CB4E-4F22-A702-7E4EA394D53A

Q35034130-2B6351E7-EBF8-4540-AE8B-A9E87B1AF790

Q35034130-31B5FD15-901F-4807-828D-13C6C3B7BFA8

Q35034130-370D2804-CE94-4456-A791-1A85AAE2809A

Q35034130-39AF90A1-4E6F-44A2-B692-5C9E3EFDE4B9

Q35034130-3C3C6C12-FAAB-4DE5-BDC1-7FD36BD782E0

P304

Q35034130-610844FF-07F5-438E-914A-5E318E3F80BD

P31

Q35034130-CEA92328-C0F8-4A1C-8D24-37859F4838C8

P356

Q35034130-EE24A93D-9699-4037-915B-4DCFFC304ADB

P407

Q35034130-AA0C68B3-A686-4483-8310-165E691FFBB0

P433

Q35034130-E19BDFFC-0AA7-4147-AE90-496BCBA12A70

P478

Q35034130-2AD8E6E4-58B4-417C-963D-B49E0A61BC66

P50

Q35034130-0D2346E4-E9F9-4585-8E90-C35DA7E01731

Q35034130-11C00C6E-60E9-4FF6-8B7C-5A1805114F5D

Q35034130-12C0C8D8-5F0F-4278-A51C-2A27FC611FCB

Q35034130-19C35366-6B63-4A88-806C-0132BDFD0672

Q35034130-1DF061FE-ADAB-448F-AEE0-4BFE4673E39B

Q35034130-2A9D7B41-38A2-4916-96B2-BC025548788D

Q35034130-2F28F7F6-1594-493A-AE92-78278F7DC5D9

Q35034130-4A547464-25A3-4F73-B981-E82018A2C48A

Q35034130-4D749B39-17BC-4366-97AF-13F777EC3355

Q35034130-51D1FA98-D57A-4916-8145-89693A8A890B

P577

Q35034130-EB8FC0CE-287F-4F5A-A78B-732D2961EFFF

P5875

Q35034130-B0AAB306-BEA8-4665-B5FD-1930EC9037A2

P698

Q35034130-1843CC9D-DCBF-4A0C-9C63-407369262885

P921

Q35034130-00661E26-F4D9-44E9-BC95-5E6FBF629A86

P932

Q35034130-8155BE11-8033-4A42-9D14-9E48631C2E5A

P356

ARCHGENPSYCHIATRY.2010.78

P1433

JAMA Psychiatry

P1476

Association of plasma clusteri ...... gression in Alzheimer disease.

@en

P2093

Alan Evans

http://www.w3.org/2001/XMLSchema#string

Andreas Güntert

http://www.w3.org/2001/XMLSchema#string

Andrew Simmons

http://www.w3.org/2001/XMLSchema#string

Catherine Foy

http://www.w3.org/2001/XMLSchema#string

Catherine Tunnard

http://www.w3.org/2001/XMLSchema#string

Christian Spenger

http://www.w3.org/2001/XMLSchema#string

Darragh O'Brien

http://www.w3.org/2001/XMLSchema#string

David R Howlett

http://www.w3.org/2001/XMLSchema#string

Dean F Wong

http://www.w3.org/2001/XMLSchema#string

Fahd Choudhry

http://www.w3.org/2001/XMLSchema#string

P2860

The extracellular chaperone clusterin influences amyloid formation and toxicity by interacting with prefibrillar structures

Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease

Neuropathological stageing of Alzheimer-related changes

Mild cognitive impairment: clinical characterization and outcome

Clusterin promotes amyloid plaque formation and is critical for neuritic toxicity in a mouse model of Alzheimer's disease

Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease

An automated method for neuroanatomic and cytoarchitectonic atlas-based interrogation of fMRI data sets

An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest

Automatically parcellating the human cerebral cortex

Neuroimaging in Alzheimer disease: an evidence-based review.

P304

739-748

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1001/ARCHGENPSYCHIATRY.2010.78

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

67

http://www.w3.org/2001/XMLSchema#string

P50

Simon Lovestone

Iwona Kłoszewska

Hilkka Soininen

Lars-Olof Wahlund

Cathy Mitchelmore

P577

2010-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

45094491

http://www.w3.org/2001/XMLSchema#string

P698

20603455

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

P932

3111021

http://www.w3.org/2001/XMLSchema#string